By linking FnBPA5 to fluorophores, radioligands, or therapeutic agents, it can specifically target tissues containing untensed fibronectin fibers (25), such as in cancer and fibrotic stroma in mice (12–15) and human (17, 18). The gene discussed is FN1; the disease is cancer.